Bionano Genomics, Inc. financial data

Symbol
BNGO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
9540 Towne Centre Drive, Suite 100, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
BioNanomatrix Inc (to 3/24/2011)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 166 % -63.5%
Quick Ratio 45.8 % -46.3%
Debt-to-equity 80.7 % +263%
Return On Equity -216 % -260%
Return On Assets -119 % -143%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 86M shares +143%
Common Stock, Shares, Outstanding 70.8M shares +113%
Entity Public Float 201M USD -49.7%
Common Stock, Value, Issued 7K USD +133%
Weighted Average Number of Shares Outstanding, Basic 67.6M shares +115%
Weighted Average Number of Shares Outstanding, Diluted 67.6M shares +115%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 36.6M USD +16.1%
Research and Development Expense 42.1M USD -23.9%
Costs and Expenses 197M USD +27.2%
Operating Income (Loss) -186M USD -26.9%
Nonoperating Income (Expense) -17.8M USD -936%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -204M USD -41.1%
Income Tax Expense (Benefit) 11K USD -99.4%
Net Income (Loss) Attributable to Parent -204M USD -39.3%
Earnings Per Share, Basic -5.18 USD/shares +10.8%
Earnings Per Share, Diluted -5.18 USD/shares +10.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.4M USD -29.8%
Accounts Receivable, after Allowance for Credit Loss, Current 6.26M USD -17.8%
Inventory, Net 23.1M USD -28.7%
Other Assets, Current 976K USD -59.5%
Assets, Current 60.6M USD -50.6%
Property, Plant and Equipment, Net 24.9M USD +22.7%
Operating Lease, Right-of-Use Asset 4.22M USD -37%
Intangible Assets, Net (Excluding Goodwill) 30M USD -20.1%
Goodwill 0 USD -100%
Other Assets, Noncurrent 5.89M USD +96.3%
Assets 129M USD -52.3%
Accounts Payable, Current 8.73M USD -26.7%
Employee-related Liabilities, Current 3.61M USD -39.1%
Accrued Liabilities, Current 5.53M USD -33.5%
Contract with Customer, Liability, Current 1.15M USD +17.3%
Liabilities, Current 37.2M USD +11%
Contract with Customer, Liability, Noncurrent 272K USD +46.2%
Operating Lease, Liability, Noncurrent 2.24M USD -53%
Liabilities 49M USD -13.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3K USD +99%
Retained Earnings (Accumulated Deficit) -629M USD -48.1%
Stockholders' Equity Attributable to Parent 80.3M USD -62.6%
Liabilities and Equity 129M USD -52.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.1M USD +13.2%
Net Cash Provided by (Used in) Financing Activities -21.6M USD -245%
Net Cash Provided by (Used in) Investing Activities 47.6M USD +188%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 70.8M shares +113%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.19M USD -122%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.8M USD +43.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.62M USD +7295%
Deferred Tax Assets, Valuation Allowance 111M USD -9.26%
Deferred Tax Assets, Gross 120M USD -10%
Operating Lease, Liability 4.38M USD -35.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -204M USD -40.6%
Lessee, Operating Lease, Liability, to be Paid 4.82M USD -37.8%
Property, Plant and Equipment, Gross 42.4M USD +36.4%
Operating Lease, Liability, Current 2.14M USD +6.21%
Lessee, Operating Lease, Liability, to be Paid, Year Two 545K USD -80.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.61M USD -2.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 440K USD -54.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 254K USD -65.2%
Deferred Tax Assets, Operating Loss Carryforwards 92M USD -16.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.99M USD -31.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 669K USD +3.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.01M USD -5.74%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 13M USD -33%
Interest Expense 5.17M USD +1639%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%